//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...









Loading...
Curious how to best teach lung US? 👨‍🏫 Just out in #journal_CHESTCritCare, Rajamani & colleagues 1️⃣ outline development of the LUCC-Lung 🫁 protocol & 2️⃣ compare it to the BLUE 🔵 protocol for novice USers: www.chestcc.org/article/S294... #POCUS #ICU @accpchest.bsky.social
2d
🎉 It's here! #journal_CHESTCritCare has its 1st 🌟IMPACT FACTOR🌟 What do you think it is? (Look-up 👀 the answer at chestcc.org where you'll also find all our content, all #OpenAccess‼️)
😫 Designing #ICU trials is hard… …but details matter… Dionne & colleagues 👀 at the impact of central vs site adjudication of a 🔑 outcome: www.chestcc.org/article/S294... ❓ wanna know if it matters? Read about it #OpenAccess in #journal_CHESTCritCare! @accpchest.bsky.social
Got a restful weekend planned? 😴 If so… 👂 To an amazing new ⭐️podcast⭐️ w #journal_CHESTCritCare Co-Host G Sacha interviewing Mangaoang & Lee, authors of 2️⃣ linked studies on a scary #ICU topic — being undersedated while paralyzed 😳 Podcast: www.chestnet.org/guidelines-a... @accpchest.bsky.social
I ❤️ when researchers use shortages to learn things, don’t you? 🫗 Kawada, Takahashi, & Fujii use a fentanyl shortage to understand the potential value of remifentanil in the #ICU: www.chestcc.org/article/S294... #OpenAccess in #journal_CHESTCritCare! @accpchest.bsky.social
🦠 Tired of MDRO infections & looking for better ways to prevent in-ICU spread? L Huerta & colleagues look at feasibility of targeted MRSA/VRE contact precautions 🎯: www.chestcc.org/article/S294... ❓ Can we ⬇️ contact days without ⬆️ infection? #journal_CHESTCritCare @accpchest.bsky.social
⚖️ As #ICU clinicians, we need to balance patient care & our safety… B van Leer et al look into radiation ☢️ exposure from PET/CT for nurses & doctors 👨‍⚕️👩‍⚕️: www.chestcc.org/article/S294... #OpenAcces in #journal_CHESTCritCare @accpchest.bsky.social
❓ Ever heard of the 💫Integrated Stress Response💫 ❓ (…it pertains to how cells respond to stress…) Just out in #journal_CHESTCritCare, Nair et al review what we know of it in #ICU: www.chestcc.org/article/S294... 🔑 take-aways: 1. It’s activated 2. Unclear assoc w outcomes @accpchest.bsky.social
📦 It’s here: #journal_CHESTCritCare’s June 2026 issue! (Vol 4, Iss 2) Jam packed with: ✔️ 13 original res papers ✔️ 2 res letters ✔️ 3 editorials ✔️ 4 HIDIs ✔️ 1 special feature ✔️ 2 CIPCs ✔️ 5 correspondences www.chestcc.org/current #OpenAccess w something for everyone! 🎉 @accpchest.bsky.social
🤔 Wondering why you don’t get Bayesian stats? ✔️ out Greendyk, Plens, & Goligher’s ⭐️editorial⭐️ in #journal_CHESTCritcare calling for better education 📣: Ed: www.chestcc.org/article/S294... Art: www.chestcc.org/article/S294... @accpchest.bsky.social
4d
9d
9d
27d
16d
27d
18d
9d
18d
chestcc.org
Home Page: CHEST Critical Care
www.chestcc.org
Central adjudication of the trial outcome of clinically important upper gastrointestinal bleeding may generate more credible outcome ascertainment, but reduced the overall event rate by 40%. If site-s...
Implications of central adjudication for the primary outcome in an international randomized trial
Hayley Gershengorn
Despite a slight reduction in patient-days spent in contact precautions during the targeted contact precautions periods, no statistically significant difference was found in hospital-acquired MRSA and...
Targeted vs Standard Contact Precautions and Transmission of MRSA and VRE in Critically Ill Adults: A Pilot Clinical Trial
www.chestcc.org
www.chestcc.org
Association of Remifentanil and Fentanyl Use with Clinical Outcomes in Critically Ill Patients: An Observational Study
Hayley Gershengorn
Hayley Gershengorn
Hayley Gershengorn
Hayley Gershengorn
Hayley Gershengorn
Hayley Gershengorn
Hayley Gershengorn
Hayley Gershengorn
Hayley Gershengorn
www.chestcc.org
Beyond the Bayesian-Frequentist Divide in Clinical Trial Design: A Call for Better Statistical Education
😵‍💫 Are you confused by Bayesian methods? Do you worry you’re alone? 🫢 Just in #journal_CHESTCritCare, B Malley et al eval how intensivists differently interpret results from Bayesian and frequentist trials… www.chestcc.org/article/S294... …I’m a bit unsettled 😉 @accpchest.bsky.social
3mo
Hayley Gershengorn